ANCA vasculitis research shifts toward personalised medicine as new studies probe immune origins and treatment risks
Eleven new studies on ANCA-associated vasculitis reveal transient pandemic-era incidence shifts, qualitative B-cell immune signatures, checkpoint biomarkers predicting rituximab failure, ...
